APPLICATION
ANDA071229
TYPE
ANDA
ORIGINAL APPROVAL
1987-04-01
LATEST ACTION
1997-12-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
IBUPROFENDiscontinued
IBUPROFEN 200MG · TABLET · ORAL
Approval history
1997-12-05Manufacturing (CMC) · Supplement 12AP
1997-02-24Manufacturing (CMC) · Supplement 11AP
1995-06-22Manufacturing (CMC) · Supplement 10AP
1994-01-12Manufacturing (CMC) · Supplement 9AP
1992-12-14Manufacturing (CMC) · Supplement 8AP
1989-01-13Manufacturing (CMC) · Supplement 3AP
1989-01-13Manufacturing (CMC) · Supplement 6AP
1988-06-17Manufacturing (CMC) · Supplement 5AP
1987-08-27Manufacturing (CMC) · Supplement 2AP
1987-07-17Manufacturing (CMC) · Supplement 1AP
1987-04-01OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.